Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism in ARV-Naive HIV-Infected Subjects.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Aug 2015
At a glance
- Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Lopinavir/ritonavir (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacogenomic
- 06 Mar 2013 Results of the adipose tissue sub-study presented at the 20th Conference on Retroviruses and Opportunistic Infections.
- 21 Feb 2013 Planned end date changed from 1 Mar 2011 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 02 Apr 2010 Planned end date changed from 1 Jul 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.